K. S. Babitha

407 total citations
41 papers, 280 citations indexed

About

K. S. Babitha is a scholar working on Inorganic Chemistry, Organic Chemistry and Physical and Theoretical Chemistry. According to data from OpenAlex, K. S. Babitha has authored 41 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Inorganic Chemistry, 18 papers in Organic Chemistry and 18 papers in Physical and Theoretical Chemistry. Recurrent topics in K. S. Babitha's work include Crystal structures of chemical compounds (24 papers), Crystallography and molecular interactions (18 papers) and Synthesis and biological activity (9 papers). K. S. Babitha is often cited by papers focused on Crystal structures of chemical compounds (24 papers), Crystallography and molecular interactions (18 papers) and Synthesis and biological activity (9 papers). K. S. Babitha collaborates with scholars based in India, Germany and Slovakia. K. S. Babitha's co-authors include B.T. Gowda, S. Foro, Kapaettu Satyamoorthy, Sabine Foro, H. Fuess, Hartmut Fuess, S. C. Gurumurthy, Ingrid Svoboda, Jozef Kožı́šek and I. Das and has published in prestigious journals such as European Journal of Medicinal Chemistry, Pharmacological Research and Molecular and Cellular Biochemistry.

In The Last Decade

K. S. Babitha

37 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. S. Babitha India 9 111 109 97 92 43 41 280
Élise Champeil United States 13 34 0.3× 224 2.1× 128 1.3× 30 0.3× 18 0.4× 29 415
Felix J. Baerlocher Canada 14 64 0.6× 105 1.0× 319 3.3× 24 0.3× 18 0.4× 31 467
Krzysztof M. Borys Poland 11 46 0.4× 133 1.2× 292 3.0× 32 0.3× 28 0.7× 19 430
Adi Haber Israel 11 105 0.9× 122 1.1× 47 0.5× 18 0.2× 85 2.0× 33 404
S. Amirthaganesan India 9 42 0.4× 89 0.8× 289 3.0× 20 0.2× 17 0.4× 20 390
Marcin K. Chmielewski Poland 13 28 0.3× 269 2.5× 150 1.5× 18 0.2× 23 0.5× 43 403
Ran An China 11 34 0.3× 106 1.0× 198 2.0× 18 0.2× 10 0.2× 33 341
Ryjul W. Stokes United States 9 83 0.7× 143 1.3× 295 3.0× 9 0.1× 32 0.7× 17 521
Aurélien Lebrun France 12 33 0.3× 154 1.4× 203 2.1× 15 0.2× 30 0.7× 40 390
Renata Paprocka Poland 10 57 0.5× 82 0.8× 335 3.5× 11 0.1× 32 0.7× 23 471

Countries citing papers authored by K. S. Babitha

Since Specialization
Citations

This map shows the geographic impact of K. S. Babitha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. S. Babitha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. S. Babitha more than expected).

Fields of papers citing papers by K. S. Babitha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. S. Babitha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. S. Babitha. The network helps show where K. S. Babitha may publish in the future.

Co-authorship network of co-authors of K. S. Babitha

This figure shows the co-authorship network connecting the top 25 collaborators of K. S. Babitha. A scholar is included among the top collaborators of K. S. Babitha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. S. Babitha. K. S. Babitha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, I., et al.. (2025). Photodynamic therapy meets nanotechnology: A synergistic approach for cancer treatment. Translational Oncology. 62. 102571–102571.
2.
3.
Das, I., et al.. (2025). Targeting neuroblastoma with hydroxamic acid based HDAC1 and HDAC2 inhibitors: Insights from in vitro and in vivo studies. Investigational New Drugs. 43(4). 780–791. 2 indexed citations
4.
Babitha, K. S., et al.. (2025). Unlocking cardiac health: exploring the role of class I HDACs in cardiovascular diseases. Molecular and Cellular Biochemistry. 480(11). 5613–5637.
5.
Babitha, K. S., et al.. (2024). Polymeric Nanostructures Revolutionizing Cervical Cancer: Diagnostics, Therapeutics, and Theranostics. BioNanoScience. 14(4). 3906–3933. 9 indexed citations
6.
Babitha, K. S., et al.. (2024). Molecular Mutations in Histiocytosis: A Comprehensive Survey of Genetic Alterations. Molecular Biotechnology. 67(2). 438–455. 4 indexed citations
7.
Satyamoorthy, Kapaettu, et al.. (2024). Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment. European Journal of Medicinal Chemistry. 269. 116324–116324. 2 indexed citations
8.
Babitha, K. S., et al.. (2024). Advancing Autonomous Nanomedicine: Bridging the Gap from Concept to Potential Clinical Studies. Journal of Cluster Science. 35(8). 2607–2635. 2 indexed citations
9.
Mal, Sib Sankar, et al.. (2024). Spectroscopic evaluation of sesame and mustard oils treated with Murchana method. Lasers in Medical Science. 39(1). 99–99. 2 indexed citations
10.
Babitha, K. S., et al.. (2024). Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention. Inflammopharmacology. 32(4). 2109–2123. 6 indexed citations
11.
Das, Kuheli, K. S. Babitha, Sudeshna Kar, et al.. (2023). Structural elucidation of a Mn(III) derivative anchored with a tetradentate Schiff base precursor: in vitro cytotoxicity study. Chemical Papers. 77(4). 1989–1998. 2 indexed citations
12.
Gurumurthy, S. C., et al.. (2023). Enhanced Bactericidal Effects and Drug Delivery with Gentamicin-Conjugated Nanoparticles. Journal of Cluster Science. 35(2). 371–390. 19 indexed citations
13.
Kumar, Avinash, et al.. (2022). Identification of potent HDAC 2 inhibitors using E-pharmacophore modelling, structure-based virtual screening and molecular dynamic simulation. Journal of Molecular Modeling. 28(5). 119–119. 10 indexed citations
14.
Satyamoorthy, Kapaettu, et al.. (2021). Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy. Pharmacological Research. 170. 105695–105695. 50 indexed citations
15.
Gowda, B.T., et al.. (2009). 2,4-Dimethyl-N-phenylbenzenesulfonamide. Acta Crystallographica Section E Structure Reports Online. 65(3). o576–o576. 15 indexed citations
16.
Gowda, B.T., S. Foro, K. S. Babitha, & H. Fuess. (2008). N-(3,5-Dichlorophenyl)benzenesulfonamide. Acta Crystallographica Section E Structure Reports Online. 64(11). o2190–o2190. 7 indexed citations
17.
Gowda, B.T., et al.. (2008). 3-Chlorophenyl 4-methylbenzoate. Acta Crystallographica Section E Structure Reports Online. 64(8). o1390–o1390. 1 indexed citations
18.
Gowda, B.T., Sabine Foro, K. S. Babitha, & Hartmut Fuess. (2008). N-(2-Methylphenyl)benzenesulfonamide. Acta Crystallographica Section E Structure Reports Online. 64(9). o1692–o1692. 8 indexed citations
19.
Gowda, B.T., et al.. (2007). 4-Methylphenyl 4-methylbenzoate. Acta Crystallographica Section E Structure Reports Online. 63(9). o3867–o3867. 5 indexed citations
20.
Gowda, B.T., et al.. (2007). 4,6-Dimethylbenzene-1,3-disulfonamide. Acta Crystallographica Section E Structure Reports Online. 63(8). o3361–o3361. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Élise Champeil Breakdown of academic impact, for papers by Felix J. Baerlocher Breakdown of academic impact, for papers by Krzysztof M. Borys Breakdown of academic impact, for papers by Adi Haber Breakdown of academic impact, for papers by S. Amirthaganesan Breakdown of academic impact, for papers by Marcin K. Chmielewski Breakdown of academic impact, for papers by Ran An Breakdown of academic impact, for papers by Ryjul W. Stokes Breakdown of academic impact, for papers by Aurélien Lebrun Breakdown of academic impact, for papers by Renata Paprocka
Rankless by CCL
2026